Global Lassa Fever Treatment Market Research Report 2023

December 2023 | 92 pages | ID: G28CB5C9FE68EN
QYResearch

Abstracts

Lassa fever is an animal-borne, or zoonotic, acute viral illness. It is endemic in parts of West Africa including Sierra Leone, Liberia, Guinea and Nigeria. Neighboring countries are also at risk, as the animal vector for Lassa virus, the “multimammate rat” (Mastomys natalensis) is distributed throughout the region. Ribavirin given intravenously and early in the course of illness is an effective treatment, in addition to support of fluid and electrolytes, oxygenation, and blood pressure.

According to QYResearch’s new survey, global Lassa Fever Treatment market is projected to reach US$ 1159 million in 2029, increasing from US$ 733 million in 2022, with the CAGR of 6.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lassa Fever Treatment market research.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Lassa Fever Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

• Pfizer
• Teva Pharmaceutical
• Mylan
• Novartis
• Sanofi
• GlaxoSmithKline
• Merck
• Otsuka Pharmaceutical
• Abbott Laboratories
• Cipla

Segment by Type

• Medications
• Supportive Care
• Others

Segment by Application

• Hospitals
• Diagnostic Centers
• Clinics
• Others

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

The Lassa Fever Treatment report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Lassa Fever Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Medications
  1.2.3 Supportive Care
  1.2.4 Others
1.3 Market by Application
  1.3.1 Global Lassa Fever Treatment Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Hospitals
  1.3.3 Diagnostic Centers
  1.3.4 Clinics
  1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Lassa Fever Treatment Market Perspective (2018-2029)
2.2 Lassa Fever Treatment Growth Trends by Region
  2.2.1 Global Lassa Fever Treatment Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Lassa Fever Treatment Historic Market Size by Region (2018-2023)
  2.2.3 Lassa Fever Treatment Forecasted Market Size by Region (2024-2029)
2.3 Lassa Fever Treatment Market Dynamics
  2.3.1 Lassa Fever Treatment Industry Trends
  2.3.2 Lassa Fever Treatment Market Drivers
  2.3.3 Lassa Fever Treatment Market Challenges
  2.3.4 Lassa Fever Treatment Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Lassa Fever Treatment Players by Revenue
  3.1.1 Global Top Lassa Fever Treatment Players by Revenue (2018-2023)
  3.1.2 Global Lassa Fever Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Lassa Fever Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lassa Fever Treatment Revenue
3.4 Global Lassa Fever Treatment Market Concentration Ratio
  3.4.1 Global Lassa Fever Treatment Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Lassa Fever Treatment Revenue in 2022
3.5 Lassa Fever Treatment Key Players Head office and Area Served
3.6 Key Players Lassa Fever Treatment Product Solution and Service
3.7 Date of Enter into Lassa Fever Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 LASSA FEVER TREATMENT BREAKDOWN DATA BY TYPE

4.1 Global Lassa Fever Treatment Historic Market Size by Type (2018-2023)
4.2 Global Lassa Fever Treatment Forecasted Market Size by Type (2024-2029)

5 LASSA FEVER TREATMENT BREAKDOWN DATA BY APPLICATION

5.1 Global Lassa Fever Treatment Historic Market Size by Application (2018-2023)
5.2 Global Lassa Fever Treatment Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Lassa Fever Treatment Market Size (2018-2029)
6.2 North America Lassa Fever Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Lassa Fever Treatment Market Size by Country (2018-2023)
6.4 North America Lassa Fever Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Lassa Fever Treatment Market Size (2018-2029)
7.2 Europe Lassa Fever Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Lassa Fever Treatment Market Size by Country (2018-2023)
7.4 Europe Lassa Fever Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Lassa Fever Treatment Market Size (2018-2029)
8.2 Asia-Pacific Lassa Fever Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Lassa Fever Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Lassa Fever Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Lassa Fever Treatment Market Size (2018-2029)
9.2 Latin America Lassa Fever Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Lassa Fever Treatment Market Size by Country (2018-2023)
9.4 Latin America Lassa Fever Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Lassa Fever Treatment Market Size (2018-2029)
10.2 Middle East & Africa Lassa Fever Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Lassa Fever Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Lassa Fever Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Pfizer
  11.1.1 Pfizer Company Detail
  11.1.2 Pfizer Business Overview
  11.1.3 Pfizer Lassa Fever Treatment Introduction
  11.1.4 Pfizer Revenue in Lassa Fever Treatment Business (2018-2023)
  11.1.5 Pfizer Recent Development
11.2 Teva Pharmaceutical
  11.2.1 Teva Pharmaceutical Company Detail
  11.2.2 Teva Pharmaceutical Business Overview
  11.2.3 Teva Pharmaceutical Lassa Fever Treatment Introduction
  11.2.4 Teva Pharmaceutical Revenue in Lassa Fever Treatment Business (2018-2023)
  11.2.5 Teva Pharmaceutical Recent Development
11.3 Mylan
  11.3.1 Mylan Company Detail
  11.3.2 Mylan Business Overview
  11.3.3 Mylan Lassa Fever Treatment Introduction
  11.3.4 Mylan Revenue in Lassa Fever Treatment Business (2018-2023)
  11.3.5 Mylan Recent Development
11.4 Novartis
  11.4.1 Novartis Company Detail
  11.4.2 Novartis Business Overview
  11.4.3 Novartis Lassa Fever Treatment Introduction
  11.4.4 Novartis Revenue in Lassa Fever Treatment Business (2018-2023)
  11.4.5 Novartis Recent Development
11.5 Sanofi
  11.5.1 Sanofi Company Detail
  11.5.2 Sanofi Business Overview
  11.5.3 Sanofi Lassa Fever Treatment Introduction
  11.5.4 Sanofi Revenue in Lassa Fever Treatment Business (2018-2023)
  11.5.5 Sanofi Recent Development
11.6 GlaxoSmithKline
  11.6.1 GlaxoSmithKline Company Detail
  11.6.2 GlaxoSmithKline Business Overview
  11.6.3 GlaxoSmithKline Lassa Fever Treatment Introduction
  11.6.4 GlaxoSmithKline Revenue in Lassa Fever Treatment Business (2018-2023)
  11.6.5 GlaxoSmithKline Recent Development
11.7 Merck
  11.7.1 Merck Company Detail
  11.7.2 Merck Business Overview
  11.7.3 Merck Lassa Fever Treatment Introduction
  11.7.4 Merck Revenue in Lassa Fever Treatment Business (2018-2023)
  11.7.5 Merck Recent Development
11.8 Otsuka Pharmaceutical
  11.8.1 Otsuka Pharmaceutical Company Detail
  11.8.2 Otsuka Pharmaceutical Business Overview
  11.8.3 Otsuka Pharmaceutical Lassa Fever Treatment Introduction
  11.8.4 Otsuka Pharmaceutical Revenue in Lassa Fever Treatment Business (2018-2023)
  11.8.5 Otsuka Pharmaceutical Recent Development
11.9 Abbott Laboratories
  11.9.1 Abbott Laboratories Company Detail
  11.9.2 Abbott Laboratories Business Overview
  11.9.3 Abbott Laboratories Lassa Fever Treatment Introduction
  11.9.4 Abbott Laboratories Revenue in Lassa Fever Treatment Business (2018-2023)
  11.9.5 Abbott Laboratories Recent Development
11.10 Cipla
  11.10.1 Cipla Company Detail
  11.10.2 Cipla Business Overview
  11.10.3 Cipla Lassa Fever Treatment Introduction
  11.10.4 Cipla Revenue in Lassa Fever Treatment Business (2018-2023)
  11.10.5 Cipla Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Lassa Fever Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Medications
Table 3. Key Players of Supportive Care
Table 4. Key Players of Others
Table 5. Global Lassa Fever Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Lassa Fever Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Lassa Fever Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Lassa Fever Treatment Market Share by Region (2018-2023)
Table 9. Global Lassa Fever Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global Lassa Fever Treatment Market Share by Region (2024-2029)
Table 11. Lassa Fever Treatment Market Trends
Table 12. Lassa Fever Treatment Market Drivers
Table 13. Lassa Fever Treatment Market Challenges
Table 14. Lassa Fever Treatment Market Restraints
Table 15. Global Lassa Fever Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Lassa Fever Treatment Market Share by Players (2018-2023)
Table 17. Global Top Lassa Fever Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lassa Fever Treatment as of 2022)
Table 18. Ranking of Global Top Lassa Fever Treatment Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by Lassa Fever Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Lassa Fever Treatment Product Solution and Service
Table 22. Date of Enter into Lassa Fever Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Lassa Fever Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Lassa Fever Treatment Revenue Market Share by Type (2018-2023)
Table 26. Global Lassa Fever Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global Lassa Fever Treatment Revenue Market Share by Type (2024-2029)
Table 28. Global Lassa Fever Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Lassa Fever Treatment Revenue Market Share by Application (2018-2023)
Table 30. Global Lassa Fever Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global Lassa Fever Treatment Revenue Market Share by Application (2024-2029)
Table 32. North America Lassa Fever Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America Lassa Fever Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Lassa Fever Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe Lassa Fever Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe Lassa Fever Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Lassa Fever Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific Lassa Fever Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific Lassa Fever Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Lassa Fever Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America Lassa Fever Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America Lassa Fever Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Lassa Fever Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa Lassa Fever Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa Lassa Fever Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Lassa Fever Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. Pfizer Company Detail
Table 48. Pfizer Business Overview
Table 49. Pfizer Lassa Fever Treatment Product
Table 50. Pfizer Revenue in Lassa Fever Treatment Business (2018-2023) & (US$ Million)
Table 51. Pfizer Recent Development
Table 52. Teva Pharmaceutical Company Detail
Table 53. Teva Pharmaceutical Business Overview
Table 54. Teva Pharmaceutical Lassa Fever Treatment Product
Table 55. Teva Pharmaceutical Revenue in Lassa Fever Treatment Business (2018-2023) & (US$ Million)
Table 56. Teva Pharmaceutical Recent Development
Table 57. Mylan Company Detail
Table 58. Mylan Business Overview
Table 59. Mylan Lassa Fever Treatment Product
Table 60. Mylan Revenue in Lassa Fever Treatment Business (2018-2023) & (US$ Million)
Table 61. Mylan Recent Development
Table 62. Novartis Company Detail
Table 63. Novartis Business Overview
Table 64. Novartis Lassa Fever Treatment Product
Table 65. Novartis Revenue in Lassa Fever Treatment Business (2018-2023) & (US$ Million)
Table 66. Novartis Recent Development
Table 67. Sanofi Company Detail
Table 68. Sanofi Business Overview
Table 69. Sanofi Lassa Fever Treatment Product
Table 70. Sanofi Revenue in Lassa Fever Treatment Business (2018-2023) & (US$ Million)
Table 71. Sanofi Recent Development
Table 72. GlaxoSmithKline Company Detail
Table 73. GlaxoSmithKline Business Overview
Table 74. GlaxoSmithKline Lassa Fever Treatment Product
Table 75. GlaxoSmithKline Revenue in Lassa Fever Treatment Business (2018-2023) & (US$ Million)
Table 76. GlaxoSmithKline Recent Development
Table 77. Merck Company Detail
Table 78. Merck Business Overview
Table 79. Merck Lassa Fever Treatment Product
Table 80. Merck Revenue in Lassa Fever Treatment Business (2018-2023) & (US$ Million)
Table 81. Merck Recent Development
Table 82. Otsuka Pharmaceutical Company Detail
Table 83. Otsuka Pharmaceutical Business Overview
Table 84. Otsuka Pharmaceutical Lassa Fever Treatment Product
Table 85. Otsuka Pharmaceutical Revenue in Lassa Fever Treatment Business (2018-2023) & (US$ Million)
Table 86. Otsuka Pharmaceutical Recent Development
Table 87. Abbott Laboratories Company Detail
Table 88. Abbott Laboratories Business Overview
Table 89. Abbott Laboratories Lassa Fever Treatment Product
Table 90. Abbott Laboratories Revenue in Lassa Fever Treatment Business (2018-2023) & (US$ Million)
Table 91. Abbott Laboratories Recent Development
Table 92. Cipla Company Detail
Table 93. Cipla Business Overview
Table 94. Cipla Lassa Fever Treatment Product
Table 95. Cipla Revenue in Lassa Fever Treatment Business (2018-2023) & (US$ Million)
Table 96. Cipla Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Lassa Fever Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Lassa Fever Treatment Market Share by Type: 2022 VS 2029
Figure 3. Medications Features
Figure 4. Supportive Care Features
Figure 5. Others Features
Figure 6. Global Lassa Fever Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global Lassa Fever Treatment Market Share by Application: 2022 VS 2029
Figure 8. Hospitals Case Studies
Figure 9. Diagnostic Centers Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Lassa Fever Treatment Report Years Considered
Figure 13. Global Lassa Fever Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Lassa Fever Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Lassa Fever Treatment Market Share by Region: 2022 VS 2029
Figure 16. Global Lassa Fever Treatment Market Share by Players in 2022
Figure 17. Global Top Lassa Fever Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lassa Fever Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Lassa Fever Treatment Revenue in 2022
Figure 19. North America Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Lassa Fever Treatment Market Share by Country (2018-2029)
Figure 21. United States Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Lassa Fever Treatment Market Share by Country (2018-2029)
Figure 25. Germany Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Lassa Fever Treatment Market Share by Region (2018-2029)
Figure 33. China Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Lassa Fever Treatment Market Share by Country (2018-2029)
Figure 41. Mexico Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Lassa Fever Treatment Market Share by Country (2018-2029)
Figure 45. Turkey Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Lassa Fever Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Pfizer Revenue Growth Rate in Lassa Fever Treatment Business (2018-2023)
Figure 48. Teva Pharmaceutical Revenue Growth Rate in Lassa Fever Treatment Business (2018-2023)
Figure 49. Mylan Revenue Growth Rate in Lassa Fever Treatment Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in Lassa Fever Treatment Business (2018-2023)
Figure 51. Sanofi Revenue Growth Rate in Lassa Fever Treatment Business (2018-2023)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Lassa Fever Treatment Business (2018-2023)
Figure 53. Merck Revenue Growth Rate in Lassa Fever Treatment Business (2018-2023)
Figure 54. Otsuka Pharmaceutical Revenue Growth Rate in Lassa Fever Treatment Business (2018-2023)
Figure 55. Abbott Laboratories Revenue Growth Rate in Lassa Fever Treatment Business (2018-2023)
Figure 56. Cipla Revenue Growth Rate in Lassa Fever Treatment Business (2018-2023)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed